Boron neutron capture therapy for glioblastoma multiforme: Interim results from the phase I/II dose-escalation studies

Neurosurgery

Volumn 44, Issue 6, 1999, Pages 1182-1193

  Chanana, Arjun D ^a   Capala, Jacek ^a   Chadha, Manjeet ^b   Coderre, Jeffrey A ^a   Diaz, Aidnag Z ^a,c   Elowitz, Eric H ^b   Iwai, Junichi ^a   Joel, Darrel D ^a   Liu, Hunguan B ^d,e   Ma, Ruimei ^a   Pendzick, Noreen ^a   Peress, Nancy S ^f   Shady, Magdy S ^f   Slatkin, Daniel N ^a   Tyson, George W ^f   Wielopolski, Lucian ^a  

^a BROOKHAVEN NATIONAL LABORATORY   (United States)

^b BETH ISRAEL MEDICAL CENTER   (United States)

^c MONTEFIORE MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e Air Force Materiel Command   (United States)

^f STONY BROOK UNIVERSITY   (United States)

Author keywords

Boron neutron capture therapy; Boronophenylalanine; Epithermal neutrons; Glioblastoma multiforme; Malignant glioma

Indexed keywords

4 BORONOPHENYLALANINE; BORON; BORON 10; FLUORODEOXYGLUCOSE F 18; FRUCTOSE; THALLIUM 201;

ADULT; AGED; ARTICLE; BRAIN SCINTISCANNING; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; FOLLOW UP; GLIOBLASTOMA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEUTRON CAPTURE THERAPY; NEUTRON RADIATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION DOSE; SAFETY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SURVIVAL; TUMOR GROWTH;

EID: 0033017585     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006123-199906000-00013     Document Type: Article

References (36)

1. Barker FG II, Chang SM, Gutin PH, Malec MK, McDermont MW, Prados MD, Wilson CB: Survival and functional status after resection of recurrent glioblastoma multiforme. Neurosurgery 42: 709-723, 1998.
2. Bauer W, Micca P, White B: A rapid method for the direct analysis of boron in whole blood by atomic emission spectroscopy, in Soloway AH, Barth RF, Carpenter DE (eds): Advances in Neutron Capture Therapy: Proceedings of the Fifth International Symposium on Neutron Capture Therapy for Cancer. New York, Plenum Press, 1993, pp 403-407.
3. Chadha M, Capala J, Coderre JA, Elowitz EH, Iwai J, Joel DD, Liu HB, Wielopolski L, Chanana AD: Boron neutron capture therapy (BNCT) for glioblastoma multiforme (GBM) using the epithermal neutron beam at the Brookhaven National Laboratory. Int J Radiat Oncol Biol Phys 40:829-834, 1998.
4. Chanana AD, Coderre JA, Joel DD, Slatkin DN: Protocols for BNCT of glioblastoma multiforme at Brookhaven: Practical considerations, in Larsson B, Crawford J, Weinreich R (eds): Advances in Neutron Capture Therapy: Proceedings of the Seventh International Symposium on Neutron Capture Therapy for Cancer. New York, Elsevier, 1997, vol 1, pp 571-574.
5. Coderre JA, Button TM, Micca PL, Fisher C, Nawrocky MM, Liu HB: Neutron capture therapy of the 9L rat gliosarcoma using the p-boronophenylalanine-fructose complex. Int J Radiat Oncol Biol Phys 30:643-652, 1994.
6. Coderre JA, Chanana AD, Joel DD, Elowitz EH, Micca PL, Nawrocky MM, Chadha M, Gebbers JO, Shady M, Peress NS, Slatkin DN: Biodistribution of boronophenylalanine in patients with glioblastoma multiforme: Boron concentration correlates with tumor cellularity. Radiat Res 149:163-170, 1998.
7. Coderre JA, Elowitz E, Chadha M, Bergland R, Capala J, Joel DD, Liu HB, Slatkin DN, Chanana AD: Boron neutron capture therapy for glioblastoma multiforme using p-boronophenylalanine and epithermal neutrons: Trial design and early clinical results. J Neurooncol 33:141-152, 1997.
8. Coderre JA, Makar MS, Micca PL, Nawrocky MM, Liu HB, Joel DD, Slatkin DN, Amols HI: Derivations of relative biological effectiveness for the high-LET radiation produced during boron neutron capture irradiations of the 9L rat gliosarcoma in vitro and in vivo. Int J Radiat Oncol Biol Phys 27:1121-1129, 1993.
9. Cooperative Group: Cooperative Group common toxicity criteria. Int J Radiat Oncol Biol Phys 31:1361-1364, 1995.
10. Cox JD, Stetz J, Pajak TF: Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31:1341-1346, 1995.
11. Curran WJ Jr, Scott CB, Horton J, Nelson JS, Weinstein AS, Fischbach AJ, Chang CH, Rotman M, Asbell SO, Krisch RE, Nelson DF: Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst 85:704-710, 1993.
12. Davis FG, Freels S, Grutsch J, Barlas S, Brem S: Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: An analysis based on Surveillance, Epidemiology, and End Results (SEER) data, 1973-1991. J Neurosurg 88:1-10, 1998.
13. Elliott TE, Dinapoli RP, O'Fallon JR, Krook JE, Earle JD, Morton RF, Levitt R, Tshetter LK, Scheithauer BW, Pfeifle DM, Twito DI, Nelimark RA: Randomized trial of radiation therapy (RT) plus dibromodulcitol (DBD) versus RT plus BCNU in high grade astrocytoma. J Neurooncol 33:239-250, 1997.
14. Elowitz EH, Bergland RM, Coderre JA, Joel DD, Chadha M, Chanana AD: Biodistribution of p-boronophenylalanine in patients with glioblastoma multiforme for use in boron neutron capture therapy. Neurosurgery 42:463-469, 1998.
15. 10B-neutron capture therapy: Enhancement of rumor dose via beam filtration and dose rate, and the effects of these parameters on minimum boron content - A theoretical evaluation. Int J Radiat Oncol Biol Phys 11:831-840, 1985.
16. 10B(n, α)7Li reaction. Med Phys 13:50-56, 1986.
17. Fairchild RG, Kalef-Ezra J, Saraf SK, Fiarman S, Rames E, Wielopolski L, Laster BH, Wheeler FJ: Installation and testing of an optimized epithermal neutron beam at the Brookhaven Medical Research Reactor (BMRR), in Harling OK, Bernard JA, Zamenhof RG (eds): Neutron Beam Design, Development, and Performance for Neutron Capture Therapy. New York, Plenum Press, 1990, pp 185-199.
18. Halperin EC, Burger PC, Bullard DE: The fallacy of the localized supratentorial malignant glioma. Int J Radiat Oncol Biol Phys 15:505-509, 1988.
19. Hatanaka H: Clinical experience of boron-neutron capture therapy for gliomas: A comparison with conventional chemo-immunoradiotherapy, in Hatanaka H (ed): Boron-Neutron Capture Therapy for Tumors. Niigata, Nishimura Co., 1986, pp 349-379.
20. Imperato JP, Paleologos NA, Vick NA: Effects of treatment on long-term survivors with malignant astrocytomas. Ann Neurol 28:818-822, 1990.
21. International Commission on Radiological Protection: 1990 recommendations of the International Commission on Radiological Protection. Ann ICRP 60:1-77, 1991.
22. Lantos P, Vandenberg SR, Kleihues P: Tumors of the nervous system, in Graham DI, Lantos PL (eds): Greenfields Neuropathology. New York, Oxford University Press, 1997, pp 612-613.
23. Laramore GE, Wheeler FJ, Wessol DE, Stelzer KJ, Griffin TW: A tumor control curve for malignant gliomas derived from fast neutron radiotherapy data: Implications for treatment delivery and compound selection, in Larsson B, Crawford J, Weinreich R (eds): Advances in Neutron Capture Therapy: Proceedings of the Seventh International Symposium on Neutron Capture Therapy for Cancer. New York, Elsevier, 1997, vol 2, pp 580-587.
24. Liu HB, Brugger RM, Greenberg DD, Rorer DC, Hu JP, Hauptman HM: Enhancement of the epithermal neutron beam used for boron neutron capture therapy. Int J Radiat Oncol Biol Phys 28:1149-1156, 1994.
25. Liu HB, Greenberg DD, Capala J, Coderre JA, Wheeler FJ: An improved neutron collimator for brain tumor irradiation in clinical boron neutron capture therapy. Med Phys 23:2051-2060, 1996.
26. Mehta MP, Masciopinto J, Rozental J, Levin A, Chappell R, Bastin K, Miles J, Turski P, Kubsad S, Mackie T, Kinsella T: Stereotactic radiosurgery for glioblastoma multiforme: Report of a prospective study evaluating prognostic factors and analyzing long-term survival advantage. Int J Radiat Oncol Biol Phys 30:541-549, 1994.
27. Nakagawa Y, Hatanaka H: Boron neutron capture therapy: Clinical brain tumor studies. J Neurooncol 33:105-115, 1997.
28. Nakagawa K, Aoki Y, Fujimaki T, Tago M, Terahara A, Karasawa K, Sakata K, Sasaki Y, Matsutani M, Akanuma A: High-dose conformal radiotherapy influenced the pattern of failure but did not improve survival in glioblastoma multiforme. Int J Radiat Oncol Biol Phys 40:1141-1149, 1998.
29. Nelson JS, Tsukada Y, Schoenfeld D, Fulling K, Lamarche J, Peress N: Necrosis as a prognostic criterion in malignant supratentorial, astrocytic gliomas. Cancer 52:550-554, 1983.
30. Prados MD, Larson DA, Lamborn K, McDermott MW, Sneed PK, Wara WM, Chang SM, Mack EE, Krouwer HGJ, Chandler KL, Warnick RE, Davis RL, Rabbitt JE, Malec M, Levin V, Gutin PH, Phillips TL, Wilson CB: Radiation therapy and hydroxyurea followed by the combination of 6-thioguanine and BCNU for the treatment of primary malignant brain tumors. Int J Radiat Oncol Biol Phys 40:57-63, 1998.
31. Scott CB, Scarantino C, Urtasun R, Movsas B, Jones CU, Simpson JR, Fischbach AJ, Curran WJ Jr: Validation and predictive power of Radiation Therapy Oncology Group (RTOG) recursive partitioning analysis classes for malignant glioma patients: A report using RTOG 90-06. Int J Radiat Oncol Biol Phys 40:51-55, 1998.
32. Slatkin DN: A history of boron neutron capture therapy of brain tumors: Postulation of a brain radiation dose tolerance limit. Brain 114:1609-1629, 1991.
33. Sullivan FJ, Herscher LL, Cook JA, Smith J, Steinberg SM, Epstein AH, Oldfield EH, Goffman TE, Kinsella TJ, Mitchell JB, Glatstein E: National Cancer Institute (Phase II) study of high-grade glioma treated with accelerated hyperfractionated radiation and iododeoxyuridine: Results in anaplastic astrocytoma. Int J Radiat Oncol Biol Phys 30:583-590, 1994.
34. Sweet WH: Early history of development of boron neutron capture therapy of rumors. J Neurooncol 33:11-26, 1997.
35. Weitzner MA, Meyers CA, Gelke CK, Byrne KS, Cella DF, Levin VA: The functional assessment of cancer therapy (FACT) scale: Development of a brain subscale and revalidation of the general version (FACT-G) in patients with primary brain rumors. Cancer 75:1151-1161, 1995.
36. Yoshino K, Suzuki A, Mori Y, Kakihana H, Honda C, Mishima Y, Kobayashi T, Kanada K: Improvement of solubility of p-boronophenylalanine by complex formation with monosaccharides. Strahlenther Onkol 165:127-129, 1989.